Protective CD8+ T Cell Response Induced by Modified Vaccinia Virus Ankara Delivering Ebola Virus Nucleoprotein
The urgent need for vaccines against Ebola virus (EBOV) was underscored by the large outbreak in West Africa (2014–2016). Since then, several promising vaccine candidates have been tested in pre-clinical and clinical studies. As a result, two vaccines were approved for human use in 2019/2020, of...
Gespeichert in:
Autoren: | , , , , , , , , |
---|---|
Format: | Artikel |
Sprache: | Englisch |
Veröffentlicht: |
Philipps-Universität Marburg
2023
|
Schlagworte: | |
Online-Zugang: | PDF-Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
Online
PDF-VolltextSignatur: |
urn:nbn:de:hebis:04-es2023-00054 |
---|---|
Publikationsdatum: |
2023-03-06 |
Quelle: |
Erstveröffentlichung: Kupke, A.; Volz, A.; Dietzel, E.; Freudenstein, A.; Schmidt, J.; Shams-Eldin, H.; Jany, S.; Sauerhering, L.; Krähling, V.; Gellhorn Serra, M.; et al. Protective CD8+ T Cell Response Induced by Modified Vaccinia Virus Ankara Delivering Ebola Virus Nucleoprotein. Vaccines 2022, 10, 533. https://doi.org/10.3390/vaccines10040533 |
Downloads: |
32 (2024), 32 (2023) |
Lizenz: |
https://creativecommons.org/licenses/by/4.0 |
Zugangs-URL: |
https://archiv.ub.uni-marburg.de/es/2023/0005 https://doi.org/10.3390/vaccines10040533 |